Janice A. Blalock, Ph.D. is a clinical psychologist with 19 years research experience in treatments for depression and anxiety disorders, and nicotine dependence. Her research area of interest is development of smoking cessation treatments for smokers with comorbid psychiatric and medical disorders. She was the Co-P.I. on a recently completed study evaluating a depression and smoking cessation intervention for pregnant smokers. She is currently conducting a NIMH-funded study evaluating the efficacy of a combined depression and smoking cessation intervention for smokers with chronic forms of depressive disorders who enter treatment with unremitted depressive episodes. Dr. Blalock also serves as the Assistant Director for the University of Texas M. D. Anderson Cancer Center’s Tobacco Treatment Program, which provides tobacco cessation services to all M.D. Anderson cancer patients. She has interest in evaluating smoking cessation treatments that are specifically tailored to meet the needs of cancer patients who have difficulty quitting following diagnosis and has several grant submissions under review that are focused on this topic; including a NCI funded study evaluating the efficacy of a novel smoking cessation intervention for cancer patients.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)